Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Letter: Estimating "safe" levels, a hazardous undertaking

I D Bross

    Cancer Research
    |November 1, 1975
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    "Losing the war against cancer".

    New solutions : a journal of environmental and occupational health policy : NS·2012
    Same author

    Leukemia in children exposed to multiple risk factors.

    The New England journal of medicine·2010
    Same author

    The public has (rightly) lost faith in scientists.

    Nature·2000
    Same author

    Cancer mortality around French nuclear sites.

    Biometrics·1998
    Same author

    What are the underlying sources of racial differences in health?

    Annals of epidemiology·1998
    Same author

    The NSABP trials.

    The New England journal of medicine·1994
    Same journal

    Targeting Cystine Addiction Suppresses Breast Cancer Lung Metastasis.

    Cancer research·2026
    Same journal

    SEPTIN7 Enhances Tumorgenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling.

    Cancer research·2026
    Same journal

    TLR9 Agonists Potentiate Adoptive T Cell Therapy in Cancer through a B Cell-CD2 Costimulatory Axis.

    Cancer research·2026
    Same journal

    CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

    Cancer research·2026
    Same journal

    A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

    Cancer research·2026
    Same journal

    Editor's Note: Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib.

    Cancer research·2026
    See all related articles